Prothena Corp Public (PRTA) Other Non Operating Income (2013 - 2026)
Prothena Corp Public's (PRTA) quarterly Other Non Operating Income came in at $271000.0 in Q1 2026, up 293.57% year-on-year from $68856.6 in Q1 2025, and up 1331.82% quarter-over-quarter from -$22000.0 in Q4 2025.
Prothena Corp Public (PRTA) Other Non Operating Income (2013 - 2026) Analysis & Trends
Prothena Corp Public's Other Non Operating Income history runs 14 years deep, the most recent figure standing at $271000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 293.57% year-over-year to $271000.0 in Q1 2026; TTM through Mar 2026 was $83000.0, a 133.47% increase from a year earlier, with the FY2025 full-year figure at -$328000.0, down 77.3% from the prior year.
- Other Non Operating Income grew to $271000.0 in Q1 2026 per PRTA's latest filing, from -$22000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $271000.0 in Q1 2026 and bottomed at -$327000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$66000.0 (2024), against an average of -$64529.4.
- Across the five-year window, Other Non Operating Income sank 4750.0% in 2023 and surged 293.57% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$327000.0 in 2022, then soared by 37.31% to -$205000.0 in 2023, then surged by 104.39% to $9000.0 in 2024, then slumped by 344.44% to -$22000.0 in 2025, then surged by 1331.82% to $271000.0 in 2026.
- Per Business Quant, the three latest PRTA Other Non Operating Income figures stand at $271000.0 (Q1 2026), -$22000.0 (Q4 2025), and -$23000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -140,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -66,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | -77,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | -141,000.00 |
| Dec 31, 2022 | -327,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | -16,000.00 |
| Sep 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -61,000.00 |